|
|
Clinical study of AdV-tk radiogenetherapy for malignant*
|
4R44CA107745-03
|
$788,188
|
$788,188
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
3U10CA021661-32S1
|
$300,000
|
$54,000
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RADIATION THERAPY ONCOLOGY GROUP
|
5U10CA021661-32
|
$8,875,198
|
$1,597,536
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Community Clinical Oncology Program Research Base
|
5U10CA037422-20
|
$1,483,085
|
$148,309
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
RTOG Tissue Bank
|
5U24CA114734-03
|
$793,043
|
$79,304
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
American College of Radiology Imaging Network
|
5U01CA080098-09
|
$10,637,601
|
$2,393,460
|
HILLMAN, BRUCE
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Radiation Therapy Oncology Group-Statistical Center
|
5U10CA032115-26
|
$1,038,338
|
$186,900
|
Sadek, Ramses
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Novel c-Met and Tie-2 antagonists against human glioma
|
1R43CA128164-01
|
$183,826
|
$183,826
|
TONG, YOUZHI
|
ANGION BIOMEDICA CORPORATION
|
|
|
Calpain Inhibitors for Cancer Related Neuropathies
|
1R43CA121653-01A1
|
$187,907
|
$187,907
|
WEBB, ROBERT
|
AXONA, INC.
|
|
|
Bay Area Tumor Institute CCOP
|
2U10CA045461-18
|
$480,000
|
$4,800
|
FEUSNER, JAMES
|
BAY AREA TUMOR INSTITUTE
|
|
|
Genomic Profile-Based Prognostic Markers for Ependymoma
|
5R33CA097874-05
|
$528,774
|
$528,774
|
Lau, Ching
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
1P30CA125123-01
|
$1,500,000
|
$30,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-01S1
|
$111,700
|
$2,234
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$800
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$3,910
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-02
|
$333,543
|
$333,543
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Immediate Early Genes of Herpes Simplex Virus
|
5R01CA020260-31
|
$432,063
|
$432,063
|
SCHAFFER, PRISCILLA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Interactive Image Guided Closed Loop Thermal Therapy
|
5R44CA079282-06
|
$712,759
|
$712,759
|
MCNICHOLS, ROGER
|
BIOTEX, INC.
|
|
|
Meningioma: Risk Factors and Quality of Life
|
5R01CA109461-02
|
$223,524
|
$223,524
|
BLACK, PETER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Signal Transduction Pathways in Glioblastoma
|
5R01CA108633-03
|
$447,893
|
$447,893
|
CHAKRAVARTI, ARNAB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
|
1R01CA129814-01
|
$302,105
|
$302,105
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Dynamic Regulation of Ras via the NF1 tumor Suppressor
|
5R01CA111754-03
|
$280,637
|
$280,637
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Physicians' Health Study II: Prevention Trial of Vitamins
|
2R01CA097193-06A1
|
$1,550,473
|
$310,095
|
GAZIANO, J
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Image Guided Therapy
|
2P01CA067165-09A2
|
$1,099,994
|
$549,997
|
Jolesz, Ferenc
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Allergies, Genetic Susceptibility and Adult Glioma Risk
|
5R01CA114205-02
|
$399,509
|
$399,509
|
MICHAUD, DOMINIQUE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
2nd Symposium on Polyomaviruses and Human Disease
|
5R13CA110760-03
|
$10,000
|
$10,000
|
ATWOOD, WALTER
|
BROWN UNIVERSITY
|
|
|
Controlled Functionalization of Composite Magnetic Nanoparticles for Targeted Del
|
1R21CA128529-01
|
$165,496
|
$165,496
|
Sun, Shouheng
|
BROWN UNIVERSITY
|
|
|
Glycoproteins in Neural Cells and Cancer
|
5R01CA033895-25
|
$318,067
|
$318,067
|
FUKUDA, MINORU
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
|
MT1-MMP pericellular proteolysis in malignancy
|
5R01CA077470-10
|
$336,447
|
$84,112
|
STRONGIN, ALEX
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA030199-27
|
$3,387,817
|
$101,635
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
|
NanoSystems Biology Cancer Center
|
5U54CA119347-03
|
$3,507,584
|
$1,052,275
|
HEATH, JAMES
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
|
4-Peroxycyclophosphamides for Brain Tumor Therapy
|
5R01CA100074-04
|
$217,702
|
$108,851
|
STRUCK, ROBERT
|
CANCERMEDICA, LLC
|
|
|
Functional analysis of signaling to and from p53 in ca
|
5R01CA098916-06
|
$258,227
|
$25,823
|
AGARWAL, Munna
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Imaging of gene expression in glioblastoma
|
5R01CA109620-02
|
$277,775
|
$277,775
|
Basilion, James
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-18
|
$5,104,000
|
$153,120
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Modulating Base Excision Repair in Tumor Drug Resistance
|
5R01CA086357-08
|
$261,129
|
$86,173
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Tumor drug delivery systems based on polymalic acid
|
5R01CA123495-02
|
$274,041
|
$137,021
|
LJUBIMOVA, JULIA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
MECHANISMS FOR PITUITARY TUMORIGENESIS
|
5R01CA075979-09
|
$266,250
|
$266,250
|
MELMED, SHLOMO
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
GENOMIC ANALYSIS OF MEDULLOBLASTOMAS
|
5R01CA109467-04
|
$740,333
|
$740,333
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
Total Lagrangian Explicit Dynamics Finite Element Method for Brain Registration
|
7R03CA126466-02
|
$87,774
|
$87,774
|
WARFIELD, SIMON
|
CHILDREN'S HOSPITAL BOSTON
|
|
|
Brain tumor angiogenesis: Integrin ceramide signaling
|
5R01CA098568-04
|
$266,432
|
$266,432
|
ERDREICH-EPSTEIN, ANAT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
Molecular Studies of Down Syndrome Leukemia
|
5R01CA111778-03
|
$231,698
|
$231,698
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
Schwann Cells in Neurofibromatosis Type 2 (NF2)
|
1R01CA118032-01A2
|
$285,000
|
$285,000
|
RATNER, NANCY
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
Neurobehavioral Late-Effects in Pediatric Brain Tumors
|
5R01CA112182-03
|
$84,987
|
$84,987
|
RIS, M
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
Gene Transfer to Facilitate Dose-Intensification in the Treatment of Pediatric B*
|
5R21CA121578-02
|
$206,823
|
$206,823
|
Wagner, Lars
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
|
Neuroblastoma Biology and Therapy
|
5P01CA097323-05
|
$2,216,467
|
$1,108,234
|
BRODEUR, GARRETT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
Occupational Pesticide Exposure of Parents and Brain Tumor Risk in Children
|
1R03CA130028-01
|
$107,406
|
$107,406
|
BUNIN, GRETA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
The Adverse Effect of Health on Personal Goal Pursuit in Adolescents with Cancer
|
5R03CA126337-02
|
$80,593
|
$24,178
|
Schwartz, Lisa
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
|
The Role of PDGFR in Medulloblastoma Progression
|
5R01CA111835-02
|
$257,494
|
$257,494
|
MACDONALD, TOBEY
|
CHILDREN'S RESEARCH INSTITUTE
|
|
|
PEDIATRIC CHTN--AIDS CANCER RESEARCH
|
3U01CA054021-15S2
|
$828,868
|
$198,928
|
QUALMAN, STEPHEN
|
CHILDREN'S RESEARCH INSTITUTE
|
|
Total relevant funding to Neurosciences Research for this search: $143,315,649
|
